Fresenius Medical Care AG & Co. KGaA Sponsored ADR Stock

$24.37

0.04% yesterday

NYSE, Sep 03, 10:00 pm CET

ISIN

US3580291066

Symbol

FMS

Reports

Quarter | Annual

Index

CDAX, NYSE Composite

Sector

Health Care Equipment & Services

Industry

Health Care Providers & Services

Overview Dividends Analysts Charts News Strategies

Fresenius Medical Care AG & Co. KGaA Sponsored ADR Stock price

$24.36

-17.87 42.32% 5Y

NYSE, Closing price Wed, Sep 03 2025

+0.00 0.00%

ISIN

US3580291066

Symbol

FMS

Reports

Quarter | Annual

Index

CDAX, NYSE Composite

Sector

Health Care Equipment & Services

Industry

Health Care Providers & Services

Key metrics

Basic

Market capitalization

$14.3b

Enterprise Value

$24.6b

Net debt

$10.3b

Cash

$2.6b

Shares outstanding

293.4m

Valuation (TTM | estimate)

P/E

9.3 | 5.5

P/S

0.6 | 0.7

EV/Sales

1.1 | 1.1

EV/FCF

10.5

P/B

0.9

Dividends

DPS

$0.81

Yield 1Y | 5Y

3.4% | 2.8%

Growth 1Y | 5Y

26.8% | 2.6%

Payout 1Y | 3Y

30.2% | 28.9%

Increased

2 Years

Financials (TTM | estimate)

Revenue

$22.8b | $23.0b

EBITDA

$3.5b | $4.3b

EBIT

$1.6b | $2.4b

Net Income

$765.4m | $1.3b

Free Cash Flow

$2.3b

Growth (TTM | estimate)

Revenue

0.5% | 2.1%

EBITDA

-4.1% | 21.6%

EBIT

2.7% | 66.1%

Net Income

23.8% | 109.0%

Free Cash Flow

50.2%

Financial Health

Equity Ratio

43.4%

Return on Equity

3.7%

ROCE

5.4%

ROIC

4.1%

Debt/Equity

0.8

EPS

$2.6

FCF per Share

$8.0

Short interest

0.2%

Employees

112k

Rev per Employee

$200.0k

As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.

Get Started for Free Today

Fresenius Medical Care AG & Co. KGaA Sponsored ADR Stock Analysis

Unlock Scores for Free

??

25 Analysts have issued a Fresenius Medical Care AG & Co. KGaA Sponsored ADR forecast:

9x Buy

36%

12x Hold

48%

4x Sell

16%

More details on Analyst Estimates Including Price Targets

25 Analysts have issued a Fresenius Medical Care AG & Co. KGaA Sponsored ADR forecast:

Buy

36%

Hold

48%

Sell

16%

Analyst Estimates with Stock Price Targets

Financial data from Fresenius Medical Care AG & Co. KGaA Sponsored ADR

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Jun '25		+/- %
Revenue	22,759 22,759	1% 1% 100%
- Direct Costs	17,145 17,145	1% 1% 75%
Gross Profit	5,614 5,614	2% 2% 25%
- Selling and Administrative Expenses	3,660 3,660	1% 1% 16%
- Research and Development Expense	200 200	19% 19% 1%
EBITDA	3,507 3,507	4% 4% 15%
- Depreciation and Amortization	1,880 1,880	9% 9% 8%
EBIT (Operating Income) EBIT	1,627 1,627	3% 3% 7%
Net Profit	765 765	24% 24% 3%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Fresenius Medical Care AG & Co. KGaA Sponsored ADR Stock News

Neutral

PRNewsWire

●

24 days ago

Fresenius Medical Care announces first tranche of its share buyback program of up to EUR 600 million as part of its new capital allocation framework

Total volume of the initial share buyback is up to EUR 1 billion over two years Share buyback to take place until August 10, 2027 BAD HOMBURG, Germany , Aug. 11, 2025 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, announced the launch of the first tranche of its initial EUR 1 billion share buyback, which i...

Neutral

Seeking Alpha

●

30 days ago

Fresenius Medical Care AG (FMS) Q2 2025 Earnings Call Transcript

Fresenius Medical Care AG (NYSE:FMS ) Q2 2025 Earnings Call August 5, 2025 8:00 AM ET Company Participants s - Corporate Participant o - Corporate Participant P - Corporate Participant Dominik Heger - Executive VP and Head of Investor Relations, Strategic Development & Communications Helen Giza - Chair of Management Board & CEO Martin Fischer - CFO & Member of the Management Board Conference Ca...

Neutral

PRNewsWire

●

30 days ago

Fresenius Medical Care delivers strong organic revenue growth and double-digit operating income growth in the second quarter of 2025

Strong organic revenue growth1 of 7% driven by all operating segments Stable U.S. same market treatment development driven by accelerating patient inflow FME25+ savings of EUR 58 million contributed to earnings Operating income2 grew by 13% at constant currency, further driving margin expansion Stable reported operating income and 20% increase in reported net income3 Operating cash flow improve...

More Fresenius Medical Care AG & Co. KGaA Sponsored ADR News

Company Profile

Fresenius Medical Care AG & Co. KGaA engages in the provision of products and services for patients with chronic kidney failure. It also develop and manufacture a variety of health care products, which includes dialysis and non-dialysis products. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.

Head office	Germany
CEO	Helen Giza
Employees	111,513
Founded	1996
Website	www.freseniusmedicalcare.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now